SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-245367
Filing Date
2021-08-13
Accepted
2021-08-13 07:16:25
Documents
45
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d182472d10q.htm   iXBRL 10-Q 1166365
2 EX-31.1 d182472dex311.htm EX-31.1 9777
3 EX-31.2 d182472dex312.htm EX-31.2 9752
4 EX-32.1 d182472dex321.htm EX-32.1 4175
5 EX-32.2 d182472dex322.htm EX-32.2 4176
  Complete submission text file 0001193125-21-245367.txt   3298069

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA hcwb-20210630.xsd EX-101.SCH 23978
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hcwb-20210630_cal.xml EX-101.CAL 19214
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hcwb-20210630_def.xml EX-101.DEF 90101
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hcwb-20210630_lab.xml EX-101.LAB 178981
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hcwb-20210630_pre.xml EX-101.PRE 148669
11 EXTRACTED XBRL INSTANCE DOCUMENT d182472d10q_htm.xml XML 377024
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40591 | Film No.: 211169723
SIC: 2834 Pharmaceutical Preparations